Stone Run Capital, LLC Charles River Laboratories International, Inc. Transaction History

Stone Run Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $180,586 - $206,675	983 New	983 $206,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $206,704 - $283,861	1,133 New	1,133 $223,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $149,627 - $221,659	-733 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $1,533 - $2,172	6 Added 0.83%	733 $208,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $115,955 - $148,064	-330 Reduced 31.22%	727 $274,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $107,320 - $131,990	288 Added 37.45%	1,057 $436,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $226,216 - $285,798	769 New	769 $284,000

721

52M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Run Capital, LLC with notifications on news.